{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:49:52Z","timestamp":1792806592448,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1855-5","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T13:04:11Z","timestamp":1552482251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Divergent roles of prostacyclin and PGE2 in human tendinopathy"],"prefix":"10.1186","volume":"21","author":[{"given":"Filip","family":"Bergqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Wheway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Oppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie G.","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"5","key":"1855_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405008963","volume":"7","author":"G Riley","year":"2005","unstructured":"Riley G. Chronic tendon pathology: molecular basis and therapeutic implications. Expert Rev Mol Med. 2005;7(5):1\u201325.","journal-title":"Expert Rev Mol Med"},{"issue":"3\u20134","key":"1855_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vetimm.2014.01.007","volume":"158","author":"SG Dakin","year":"2014","unstructured":"Dakin SG, Dudhia J, Smith RK. Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy. Vet Immunol Immunopathol. 2014;158(3\u20134):121\u20137.","journal-title":"Vet Immunol Immunopathol"},{"issue":"2","key":"1855_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrrheum.2016.213","volume":"13","author":"NL Millar","year":"2017","unstructured":"Millar NL, Murrell GA, McInnes IB. Inflammatory mechanisms in tendinopathy - towards translation. Nat Rev Rheumatol. 2017;13(2):110\u201322.","journal-title":"Nat Rev Rheumatol"},{"issue":"8905","key":"1855_CR4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","volume":"343","author":"MJ Langman","year":"1994","unstructured":"Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343(8905):1075\u20138.","journal-title":"Lancet."},{"issue":"11","key":"1855_CR5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352(11):1092\u2013102.","journal-title":"N Engl J Med"},{"issue":"11","key":"1855_CR6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","volume":"352","author":"NA Nussmeier","year":"2005","unstructured":"Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352(11):1081\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"1855_CR7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0363546505280428","volume":"34","author":"DB Cohen","year":"2006","unstructured":"Cohen DB, Kawamura S, Ehteshami JR, Rodeo SA. Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing. Am J Sports Med. 2006;34(3):362\u20139.","journal-title":"Am J Sports Med"},{"issue":"8","key":"1855_CR8","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1177\/0363546507301584","volume":"35","author":"ST Ferry","year":"2007","unstructured":"Ferry ST, Dahners LE, Afshari HM, Weinhold PS. The effects of common anti-inflammatory drugs on the healing rat patellar tendon. Am J Sports Med. 2007;35(8):1326\u201333.","journal-title":"Am J Sports Med"},{"issue":"5","key":"1855_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1302\/2046-3758.35.2000270","volume":"3","author":"AJ Carr","year":"2014","unstructured":"Carr AJ, Rees JL, Ramsay CR, Fitzpatrick R, Gray A, Moser J, et al. Protocol for the United Kingdom Rotator Cuff Study (UKUFF): a randomised controlled trial of open and arthroscopic rotator cuff repair. Bone Joint Res. 2014;3(5):155\u201360.","journal-title":"Bone Joint Res"},{"issue":"3","key":"1855_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1855_CR11","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","volume":"111","author":"WL Smith","year":"2011","unstructured":"Smith WL, Urade Y, Jakobsson PJ. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev. 2011;111(10):5821\u201365.","journal-title":"Chem Rev"},{"issue":"5","key":"1855_CR12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986\u20131000.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6643","key":"1855_CR13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/41780","volume":"388","author":"T Murata","year":"1997","unstructured":"Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 1997;388(6643):678\u201382.","journal-title":"Nature."},{"issue":"1","key":"1855_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol. 2012;188(1):21\u20138.","journal-title":"J Immunol"},{"issue":"1","key":"1855_CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","volume":"116","author":"T Grosser","year":"2006","unstructured":"Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116(1):4\u201315.","journal-title":"J Clin Invest"},{"issue":"7","key":"1855_CR16","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1177\/0363546504263403","volume":"32","author":"O Virchenko","year":"2004","unstructured":"Virchenko O, Skoglund B, Aspenberg P. Parecoxib impairs early tendon repair but improves later remodeling. Am J Sports Med. 2004;32(7):1743\u20137.","journal-title":"Am J Sports Med"},{"issue":"3","key":"1855_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","volume":"59","author":"B Samuelsson","year":"2007","unstructured":"Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. 2007;59(3):207\u201324.","journal-title":"Pharmacol Rev"},{"issue":"311","key":"1855_CR18","doi-asserted-by":"crossref","first-page":"311ra173","DOI":"10.1126\/scitranslmed.aac4269","volume":"7","author":"SG Dakin","year":"2015","unstructured":"Dakin SG, Martinez FO, Yapp C, Wells G, Oppermann U, Dean BJ, et al. Inflammation activation and resolution in human tendon disease. Sci Transl Med. 2015;7(311):311ra173.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1855_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13075-016-1218-4","volume":"19","author":"SG Dakin","year":"2017","unstructured":"Dakin SG, Buckley CD, Al-Mossawi MH, Hedley R, Martinez FO, Wheway K, et al. Persistent stromal fibroblast activation is present in chronic tendinopathy. Arthritis Res Ther. 2017;19(1):16.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1855_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.imlet.2011.02.010","volume":"138","author":"CD Buckley","year":"2011","unstructured":"Buckley CD. Why does chronic inflammation persist: an unexpected role for fibroblasts. Immunol Lett. 2011;138(1):12\u20134.","journal-title":"Immunol Lett"},{"issue":"4","key":"1855_CR21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.berh.2014.10.022","volume":"28","author":"R Patel","year":"2014","unstructured":"Patel R, Filer A, Barone F, Buckley CD. Stroma: fertile soil for inflammation. Best Pract Res Clin Rheumatol. 2014;28(4):565\u201376.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1855_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1471-4906(01)01863-4","volume":"22","author":"CD Buckley","year":"2001","unstructured":"Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001;22(4):199\u2013204.","journal-title":"Trends Immunol"},{"issue":"2","key":"1855_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.oto.2013.05.003","volume":"23","author":"RJ Murphy","year":"2013","unstructured":"Murphy RJ, Dean BJF, Wheway K, Watkins B, Morrey ME, Carr AJ. A novel minimally invasive ultrasound-guided technique to biopsy supraspinatus tendon. Oper Tech Orthop. 2013;23(2):56\u201362.","journal-title":"Oper Tech Orthop"},{"key":"1855_CR24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.prostaglandins.2013.09.001","volume":"107","author":"P Leclerc","year":"2013","unstructured":"Leclerc P, Idborg H, Spahiu L, Larsson C, Nekhotiaeva N, Wannberg J, et al. Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation. Prostaglandins Other Lipid Mediat. 2013;107:26\u201334.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1855_CR25","doi-asserted-by":"crossref","unstructured":"Martinez FO. Analysis of gene expression and gene silencing in human macrophages. Curr Protoc Immunol. 2012;96(1):14.28.1\u201314.28.23. edited by John E Coligan [et al].","DOI":"10.1002\/0471142735.im1428s96"},{"key":"1855_CR26","doi-asserted-by":"crossref","unstructured":"Dakin SG, Newton J, Martinez FO, Hedley R, Gwilym S, Jones N, et al. Chronic inflammation is a feature of Achilles tendinopathy and rupture. Br J Sports Med. 2018;52:359\u201367.","DOI":"10.1136\/bjsports-2017-098161"},{"key":"1855_CR27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2011.00024","volume":"2","author":"J Stitham","year":"2011","unstructured":"Stitham J, Midgett C, Martin KA, Hwa J. Prostacyclin: an inflammatory paradox. Front Pharmacol. 2011;2:24.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1855_CR28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0024-3205(80)90310-0","volume":"27","author":"MJ Brodie","year":"1980","unstructured":"Brodie MJ, Hensby CN, Parke A, Gordon D. Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid? Life Sci. 1980;27(7):603\u20138.","journal-title":"Life Sci"},{"issue":"2","key":"1855_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.20051310","volume":"203","author":"T Honda","year":"2006","unstructured":"Honda T, Segi-Nishida E, Miyachi Y, Narumiya S. Prostacyclin-IP signaling and prostaglandin E2-EP2\/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med. 2006;203(2):325\u201335.","journal-title":"J Exp Med"},{"issue":"5","key":"1855_CR30","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/art.23453","volume":"58","author":"M Chen","year":"2008","unstructured":"Chen M, Boilard E, Nigrovic PA, Clark P, Xu D, Fitzgerald GA, et al. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K\/BxN serum-transfer arthritis. Arthritis Rheum. 2008;58(5):1354\u201365.","journal-title":"Arthritis Rheum"},{"key":"1855_CR31","doi-asserted-by":"crossref","first-page":"9847840","DOI":"10.1155\/2016\/9847840","volume":"2016","author":"R Sugita","year":"2016","unstructured":"Sugita R, Kuwabara H, Kubota K, Sugimoto K, Kiho T, Tengeiji A, et al. Simultaneous inhibition of PGE2 and PGI2 signals is necessary to suppress hyperalgesia in rat inflammatory pain models. Mediat Inflamm. 2016;2016:9847840.","journal-title":"Mediat Inflamm"},{"issue":"6","key":"1855_CR32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5830\/CVJA-2010-088","volume":"21","author":"MR Essop","year":"2010","unstructured":"Essop MR. Contemporary insights into the pathogenesis, diagnosis and therapy of pulmonary arterial hypertension. Cardiovasc J Afr. 2010;21(6):334\u20137.","journal-title":"Cardiovasc J Afr"},{"issue":"6","key":"1855_CR33","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jvs.2013.03.012","volume":"57","author":"GJ Landry","year":"2013","unstructured":"Landry GJ. Current medical and surgical management of Raynaud\u2019s syndrome. J Vasc Surg. 2013;57(6):1710\u20136.","journal-title":"J Vasc Surg"},{"issue":"1","key":"1855_CR34","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1038\/s41598-017-11188-y","volume":"7","author":"SG Dakin","year":"2017","unstructured":"Dakin SG, Ly L, Colas RA, Oppermann U, Wheway K, Watkins B, et al. Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy. Sci Rep. 2017;7(1):11009.","journal-title":"Sci Rep"},{"issue":"20","key":"1855_CR35","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1073\/pnas.162488599","volume":"99","author":"HY Chang","year":"2002","unstructured":"Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A. 2002;99(20):12877\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1855_CR36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14852","volume":"8","author":"M Frank-Bertoncelj","year":"2017","unstructured":"Frank-Bertoncelj M, Trenkmann M, Klein K, Karouzakis E, Rehrauer H, Bratus A, et al. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. Nat Commun. 2017;8:14852.","journal-title":"Nat Commun"},{"issue":"1","key":"1855_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00042752-200501000-00006","volume":"15","author":"MH Khan","year":"2005","unstructured":"Khan MH, Li Z, Wang JH. Repeated exposure of tendon to prostaglandin-E2 leads to localized tendon degeneration. Clin J Sport Med. 2005;15(1):27\u201333.","journal-title":"Clin J Sport Med"},{"issue":"1","key":"1855_CR38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1758-2555-4-2","volume":"4","author":"ST Ferry","year":"2012","unstructured":"Ferry ST, Afshari HM, Lee JA, Dahners LE, Weinhold PS. Effect of prostaglandin E2 injection on the structural properties of the rat patellar tendon. Sports Med Arthrosc Rehabil Ther Technol. 2012;4(1):2.","journal-title":"Sports Med Arthrosc Rehabil Ther Technol"},{"issue":"2","key":"1855_CR39","volume":"9","author":"J Zhang","year":"2014","unstructured":"Zhang J, Wang JH. Prostaglandin E2 (PGE2) exerts biphasic effects on human tendon stem cells. PLoS One. 2014;9(2):e87706.","journal-title":"PLoS One"},{"issue":"7","key":"1855_CR40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2(7):612\u20139.","journal-title":"Nat Immunol"},{"issue":"4","key":"1855_CR41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/187153006779025711","volume":"6","author":"J Akaogi","year":"2006","unstructured":"Akaogi J, Nozaki T, Satoh M, Yamada H. Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr Metab Immune Disord Drug Targets. 2006;6(4):383\u201394.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1855_CR42","doi-asserted-by":"crossref","first-page":"239310","DOI":"10.1155\/2012\/239310","volume":"2012","author":"MJ Fattahi","year":"2012","unstructured":"Fattahi MJ, Mirshafiey A. Prostaglandins and rheumatoid arthritis. Arthritis. 2012;2012:239310.","journal-title":"Arthritis."},{"issue":"39","key":"1855_CR43","doi-asserted-by":"crossref","first-page":"14507","DOI":"10.1073\/pnas.0606586103","volume":"103","author":"M Wang","year":"2006","unstructured":"Wang M, Zukas AM, Hui Y, Ricciotti E, Pure E, FitzGerald GA. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci U S A. 2006;103(39):14507\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1855_CR44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/CIRCULATIONAHA.110.973685","volume":"123","author":"M Wang","year":"2011","unstructured":"Wang M, Ihida-Stansbury K, Kothapalli D, Tamby MC, Yu Z, Chen L, et al. Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury. Circulation. 2011;123(6):631\u20139.","journal-title":"Circulation."},{"issue":"4","key":"1855_CR45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCULATIONAHA.116.022308","volume":"134","author":"SY Tang","year":"2016","unstructured":"Tang SY, Monslow J, G RG, Todd L, Pawelzik SC, Chen L, et al. Cardiovascular consequences of prostanoid I receptor deletion in microsomal prostaglandin E synthase-1-deficient hyperlipidemic mice. Circulation. 2016;134(4):328\u201338.","journal-title":"Circulation."},{"issue":"6","key":"1855_CR46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","volume":"5","author":"DW Gilroy","year":"1999","unstructured":"Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;5(6):698\u2013701.","journal-title":"Nat Med"},{"issue":"5","key":"1855_CR47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd1383","volume":"3","author":"DW Gilroy","year":"2004","unstructured":"Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov. 2004;3(5):401\u201316.","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"1855_CR48","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1096\/fj.06-6366fje","volume":"20","author":"M Kapoor","year":"2006","unstructured":"Kapoor M, Kojima F, Qian M, Yang L, Crofford LJ. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis. FASEB J. 2006;20(13):2387\u20139.","journal-title":"FASEB J"},{"issue":"2","key":"1855_CR49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1582-4934.2007.00110.x","volume":"12","author":"C Brenneis","year":"2008","unstructured":"Brenneis C, Coste O, Schmidt R, Angioni C, Popp L, Nusing RM, et al. Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice. J Cell Mol Med. 2008;12(2):639\u201348.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"1855_CR50","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/ijc.24875","volume":"126","author":"IL Beales","year":"2010","unstructured":"Beales IL, Ogunwobi OO. Microsomal prostaglandin E synthase-1 inhibition blocks proliferation and enhances apoptosis in oesophageal adenocarcinoma cells without affecting endothelial prostacyclin production. Int J Cancer. 2010;126(9):2247\u201355.","journal-title":"Int J Cancer"},{"issue":"22","key":"1855_CR51","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1111\/bph.13939","volume":"174","author":"G Ozen","year":"2017","unstructured":"Ozen G, Gomez I, Daci A, Deschildre C, Boubaya L, Teskin O, et al. Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI2: a safer alternative to COX-2 inhibition. Br J Pharmacol. 2017;174(22):4087\u201398.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1855_CR52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cpt.260","volume":"99","author":"Y Jin","year":"2016","unstructured":"Jin Y, Smith CL, Hu L, Campanale KM, Stoltz R, Huffman LG Jr, et al. Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib. Clin Pharmacol Ther. 2016;99(3):274\u201384.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1855_CR53","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI27540","volume":"116","author":"Y Cheng","year":"2006","unstructured":"Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest. 2006;116(5):1391\u20139.","journal-title":"J Clin Invest"},{"issue":"6","key":"1855_CR54","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/art.20286","volume":"50","author":"M Westman","year":"2004","unstructured":"Westman M, Korotkova M, af Klint E, Stark A, Audoly LP, Klareskog L, et al. Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. Arthritis Rheum. 2004;50(6):1774\u201380.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1855-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T19:27:39Z","timestamp":1721071659000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1855-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1855"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1855-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was granted by local research ethics committee, South Central Oxford B reference 14\/SC\/0222 (United Kingdom). Healthy hamstring and shoulder tendon tears were collected under research ethics from the Oxford Musculoskeletal Biobank (09\/H0606\/11) (United Kingdom). Tendinopathic and ruptured Achilles tendons were collected under the Office for Research Ethics Committees from Northern Ireland Research Ethics Committee (reference 14\/NI\/1063). Full informed consent according to the Declaration of Helsinki was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P-JJ is a member of the board of directors at Gesynta Pharma, a company that develops anti-inflammatory drugs. All other authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"74"}}